Skip to content

Retrosplenial Cortex Stimulation for Medial Temporal Lobe Epilepsy: A Clinical Study

Retrosplenial Cortex Stimulation for Medial Temporal Lobe Epilepsy: A Clinical Study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096181
Enrollment
Unknown
Registered
2025-01-20
Start date
2025-01-24
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Temporal Lobe Epilepsy

Interventions

Treatment group:Short time electrical stimulation using SEEG electrodes

Sponsors

Xuanwu Hospital Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 10-50 years; for participants under the age of 18, they must agree to comply with all protocol requirements, and their parents or legal guardians must be willing to provide informed consent, approved by the Institutional Review Board (IRB)/Independent Ethics Committee (IEC)/Human Research Ethics Committee (HREC), before any study-related procedures are undertaken. 2. Patients with temporal lobe epilepsy that has not been effectively controlled despite more than two years of standard treatment with antiepileptic drugs. 3. Patients who have been diagnosed with medial temporal lobe epilepsy based on multidisciplinary discussions involving neurology, neurosurgery, and radiology departments. 4. Patients scheduled to undergo stereoelectroencephalography (SEEG) implantation with electrodes covering medial temporal structures and the retrosplenial cortex (RSC) region. 5. Comprehensive preoperative evaluation has been completed, and contraindications for the corresponding surgical procedure have been excluded. 6. Patients capable of understanding the study procedures. 7. Patients who provide informed consent and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Serious neurological or mental illness; 2. Persons who are seriously dependent on drugs, alcohol or illicit drugs; 3. Can not cooperate with the completion of preoperative non-invasive evaluation examination or preoperative evaluation; 4. Patients with other surgery-related contraindications; 5. Local infection or active systemic infection at the intended surgical approach site; 6. Those who cannot receive electrode implantation due to the need for treatment or examination of other diseases; 7. Those who refuse to participate in the experiment; 8. Patients with temporal lobe epilepsy without SEEG records 9. Those deemed unsuitable by the researcher;

Design outcomes

Primary

MeasureTime frame
Hippocampal Spike Discharge Count;Hippocampal High-Frequency Oscillation Count;Length of Hippocampal Seizure Discharge Duration;

Secondary

MeasureTime frame
Intensity of Hippocampal Evoked Potentials;Safety of Electrical Stimulation of the Retrosplenial Cortex ;

Countries

China

Contacts

Public ContactWang Yihe

Department of Neurosurgery of Xuanwu Hospital Capital Medical University

Wangyh9011@163.com+86 188 1089 9617

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026